

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 8.05853828 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 8.05853828 |
| 3 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.14807364 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.09654652 |
| 5 | negative regulation of protein localization to cell surface (GO:2000009) | 4.91088894 |
| 6 | response to peptidoglycan (GO:0032494) | 4.65880586 |
| 7 | cellular extravasation (GO:0045123) | 4.61954100 |
| 8 | ensheathment of neurons (GO:0007272) | 4.32507952 |
| 9 | axon ensheathment (GO:0008366) | 4.32507952 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.30821608 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.30821608 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.30821608 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.30821608 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.30821608 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.30821608 |
| 16 | myelination (GO:0042552) | 4.30266822 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.25477577 |
| 18 | regulation of skeletal muscle contraction (GO:0014819) | 4.24732069 |
| 19 | fatty acid elongation (GO:0030497) | 4.21663092 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 4.21365929 |
| 21 | mannose metabolic process (GO:0006013) | 4.17328043 |
| 22 | creatine metabolic process (GO:0006600) | 4.17154978 |
| 23 | sarcomere organization (GO:0045214) | 4.11554870 |
| 24 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.03827725 |
| 25 | myofibril assembly (GO:0030239) | 3.84748893 |
| 26 | myelin maintenance (GO:0043217) | 3.81463679 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 3.80678223 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.76792935 |
| 29 | actin-myosin filament sliding (GO:0033275) | 3.73216698 |
| 30 | muscle filament sliding (GO:0030049) | 3.73216698 |
| 31 | import into cell (GO:0098657) | 3.57707771 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.55737925 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.55169926 |
| 34 | germinal center formation (GO:0002467) | 3.54790695 |
| 35 | detection of other organism (GO:0098543) | 3.54785508 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.47475966 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.47159208 |
| 38 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.46544754 |
| 39 | cardiac myofibril assembly (GO:0055003) | 3.45756148 |
| 40 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.40131808 |
| 41 | actin-mediated cell contraction (GO:0070252) | 3.38248303 |
| 42 | photoreceptor cell differentiation (GO:0046530) | 3.38086265 |
| 43 | eye photoreceptor cell differentiation (GO:0001754) | 3.38086265 |
| 44 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.31663890 |
| 45 | regulation of relaxation of muscle (GO:1901077) | 3.29256401 |
| 46 | membrane tubulation (GO:0097320) | 3.29216671 |
| 47 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.27176934 |
| 48 | iron ion import (GO:0097286) | 3.26986487 |
| 49 | detection of bacterium (GO:0016045) | 3.26416010 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.25719394 |
| 51 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.24965445 |
| 52 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24591879 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.23560089 |
| 54 | regulation of actin filament-based movement (GO:1903115) | 3.22631901 |
| 55 | positive regulation of B cell differentiation (GO:0045579) | 3.21484410 |
| 56 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.15374605 |
| 57 | plasma membrane repair (GO:0001778) | 3.15111660 |
| 58 | virion attachment to host cell (GO:0019062) | 3.13670185 |
| 59 | adhesion of symbiont to host cell (GO:0044650) | 3.13670185 |
| 60 | astrocyte development (GO:0014002) | 3.12686411 |
| 61 | detection of biotic stimulus (GO:0009595) | 3.11139416 |
| 62 | negative regulation of interleukin-12 production (GO:0032695) | 3.10290389 |
| 63 | myelination in peripheral nervous system (GO:0022011) | 3.08464523 |
| 64 | peripheral nervous system axon ensheathment (GO:0032292) | 3.08464523 |
| 65 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.08160221 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 3.07161102 |
| 67 | limb bud formation (GO:0060174) | 3.06287423 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.06100769 |
| 69 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.06048664 |
| 70 | negative regulation of cell killing (GO:0031342) | 3.05715654 |
| 71 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.05715654 |
| 72 | positive regulation of action potential (GO:0045760) | 3.05230132 |
| 73 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99727782 |
| 74 | pinocytosis (GO:0006907) | 2.96725779 |
| 75 | regulation of histone H3-K27 methylation (GO:0061085) | 2.96212941 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.95401810 |
| 77 | L-amino acid import (GO:0043092) | 2.94822414 |
| 78 | hemidesmosome assembly (GO:0031581) | 2.94265634 |
| 79 | adult heart development (GO:0007512) | 2.93889854 |
| 80 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.91835348 |
| 81 | actomyosin structure organization (GO:0031032) | 2.91582272 |
| 82 | membrane raft organization (GO:0031579) | 2.90977806 |
| 83 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.89716472 |
| 84 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.89590815 |
| 85 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.86708580 |
| 86 | regulation of striated muscle contraction (GO:0006942) | 2.84041160 |
| 87 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.83697190 |
| 88 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.83686544 |
| 89 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.83664912 |
| 90 | macrophage activation (GO:0042116) | 2.82312258 |
| 91 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.82158036 |
| 92 | renal filtration (GO:0097205) | 2.82145879 |
| 93 | neuron remodeling (GO:0016322) | 2.81981959 |
| 94 | cellular response to epinephrine stimulus (GO:0071872) | 2.81844972 |
| 95 | T-helper 1 type immune response (GO:0042088) | 2.79641535 |
| 96 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.79567629 |
| 97 | definitive hemopoiesis (GO:0060216) | 2.78876378 |
| 98 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.78532130 |
| 99 | oligodendrocyte differentiation (GO:0048709) | 2.78531673 |
| 100 | glomerular filtration (GO:0003094) | 2.74800026 |
| 101 | immunoglobulin mediated immune response (GO:0016064) | 2.74101849 |
| 102 | response to thyroid hormone (GO:0097066) | 2.72023396 |
| 103 | extracellular matrix assembly (GO:0085029) | 2.70949700 |
| 104 | response to laminar fluid shear stress (GO:0034616) | 2.70625219 |
| 105 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.70420690 |
| 106 | myeloid cell activation involved in immune response (GO:0002275) | 2.70083493 |
| 107 | regulation of mast cell activation (GO:0033003) | 2.69543853 |
| 108 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.67482973 |
| 109 | regulation of cell communication by electrical coupling (GO:0010649) | 2.67239259 |
| 110 | response to redox state (GO:0051775) | 2.66849123 |
| 111 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.66095799 |
| 112 | response to host immune response (GO:0052572) | 2.66095799 |
| 113 | actin filament-based movement (GO:0030048) | 2.65890379 |
| 114 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.65605775 |
| 115 | response to host (GO:0075136) | 2.65338491 |
| 116 | response to host defenses (GO:0052200) | 2.65338491 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.65338491 |
| 118 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64867038 |
| 119 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64606012 |
| 120 | presynaptic membrane organization (GO:0097090) | 2.64128244 |
| 121 | oxygen transport (GO:0015671) | 2.63359451 |
| 122 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.62584962 |
| 123 | muscle tissue morphogenesis (GO:0060415) | 2.61342868 |
| 124 | granulocyte activation (GO:0036230) | 2.60444647 |
| 125 | response to epinephrine (GO:0071871) | 2.60219726 |
| 126 | neutrophil activation (GO:0042119) | 2.59869285 |
| 127 | otic vesicle formation (GO:0030916) | 2.59058729 |
| 128 | positive regulation of mast cell activation (GO:0033005) | 2.59025185 |
| 129 | phagocytosis, recognition (GO:0006910) | 2.58880632 |
| 130 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.58234590 |
| 131 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.56543747 |
| 132 | negative regulation of interleukin-8 production (GO:0032717) | 2.54884934 |
| 133 | gas transport (GO:0015669) | 2.54672437 |
| 134 | organ growth (GO:0035265) | 2.54609302 |
| 135 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.54106580 |
| 136 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.53679649 |
| 137 | regulation of necroptotic process (GO:0060544) | 2.53090810 |
| 138 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.51079752 |
| 139 | regulation of cardiac muscle contraction (GO:0055117) | 2.50898396 |
| 140 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.50832126 |
| 141 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50523988 |
| 142 | amyloid precursor protein metabolic process (GO:0042982) | 2.49898178 |
| 143 | negative regulation of T cell mediated immunity (GO:0002710) | 2.49424093 |
| 144 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49291517 |
| 145 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.48326523 |
| 146 | positive regulation of mast cell degranulation (GO:0043306) | 2.47827639 |
| 147 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.47827639 |
| 148 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.47464498 |
| 149 | leukocyte degranulation (GO:0043299) | 2.45588508 |
| 150 | regulation of collateral sprouting (GO:0048670) | 2.44108822 |
| 151 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.44073011 |
| 152 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.43403127 |
| 153 | erythrocyte development (GO:0048821) | 2.43036714 |
| 154 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.42547205 |
| 155 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.42449196 |
| 156 | embryonic process involved in female pregnancy (GO:0060136) | 2.41877308 |
| 157 | adhesion of symbiont to host (GO:0044406) | 2.40584989 |
| 158 | regulation of lipoprotein metabolic process (GO:0050746) | 2.40123334 |
| 159 | cardiac muscle contraction (GO:0060048) | 2.40088716 |
| 160 | negative regulation of complement activation (GO:0045916) | 2.39911192 |
| 161 | regulation of regulated secretory pathway (GO:1903305) | 2.39578440 |
| 162 | microglial cell activation (GO:0001774) | 2.38688372 |
| 163 | low-density lipoprotein particle clearance (GO:0034383) | 2.38641696 |
| 164 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.38474325 |
| 165 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.37582103 |
| 166 | regulation of type 2 immune response (GO:0002828) | 2.35702258 |
| 167 | asymmetric protein localization (GO:0008105) | 2.35523693 |
| 168 | negative regulation of type 2 immune response (GO:0002829) | 2.34735078 |
| 169 | glycosphingolipid catabolic process (GO:0046479) | 2.33974101 |
| 170 | regulation of macrophage cytokine production (GO:0010935) | 2.33889701 |
| 171 | respiratory burst (GO:0045730) | 2.32681996 |
| 172 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.32337216 |
| 173 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.32174878 |
| 174 | membrane assembly (GO:0071709) | 2.31095007 |
| 175 | myeloid cell development (GO:0061515) | 2.31030790 |
| 176 | response to lipoprotein particle (GO:0055094) | 2.30793218 |
| 177 | positive regulation of osteoblast proliferation (GO:0033690) | 2.30622673 |
| 178 | oligosaccharide catabolic process (GO:0009313) | 2.29162591 |
| 179 | response to inactivity (GO:0014854) | 2.29101373 |
| 180 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.28387098 |
| 181 | apical protein localization (GO:0045176) | 2.27710117 |
| 182 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.26072798 |
| 183 | glomerular basement membrane development (GO:0032836) | 2.25448544 |
| 184 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.23463526 |
| 185 | negative regulation of neurotransmitter transport (GO:0051589) | 2.22960379 |
| 186 | lateral sprouting from an epithelium (GO:0060601) | 2.22840527 |
| 187 | regulation of sarcomere organization (GO:0060297) | 2.22799951 |
| 188 | response to catecholamine (GO:0071869) | 2.22199281 |
| 189 | response to monoamine (GO:0071867) | 2.22199281 |
| 190 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.22196945 |
| 191 | striated muscle contraction (GO:0006941) | 2.22133608 |
| 192 | short-term memory (GO:0007614) | 2.21698068 |
| 193 | cellular response to catecholamine stimulus (GO:0071870) | 2.21600615 |
| 194 | cellular response to monoamine stimulus (GO:0071868) | 2.21600615 |
| 195 | GPI anchor biosynthetic process (GO:0006506) | 2.20780881 |
| 196 | establishment of mitochondrion localization (GO:0051654) | 2.20503087 |
| 197 | regulation of membrane repolarization (GO:0060306) | 2.17428084 |
| 198 | skeletal muscle contraction (GO:0003009) | 2.16583606 |
| 199 | glycerophospholipid catabolic process (GO:0046475) | 2.16234134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.48874552 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.87844809 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.73902700 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.72403345 |
| 5 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.58435688 |
| 6 | GATA1_19941826_ChIP-Seq_K562_Human | 2.56173774 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.55764727 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50311050 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.49209811 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38770636 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33973442 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29186839 |
| 13 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.28942752 |
| 14 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.27914730 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.27153881 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26844215 |
| 17 | * NCOR1_26117541_ChIP-Seq_K562_Human | 2.24074430 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.23374939 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.19954019 |
| 20 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.17541090 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.14895245 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.13683044 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11808018 |
| 24 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.08669552 |
| 25 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.07721666 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.06185677 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.05337152 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.05208237 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.03578694 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.02096703 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01921151 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.00951795 |
| 33 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.99681649 |
| 34 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.99681649 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98337054 |
| 36 | * MAF_26560356_Chip-Seq_TH1_Human | 1.96733234 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90570605 |
| 38 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.88235312 |
| 39 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.87802798 |
| 40 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.86772980 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.86767616 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86655709 |
| 43 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.86332802 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.85463392 |
| 45 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.85179309 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80946356 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80816589 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79617153 |
| 49 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.78700672 |
| 50 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.77297956 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74935126 |
| 52 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.73704676 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.73024070 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71029035 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.68833892 |
| 56 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.67631654 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66338806 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66031455 |
| 59 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.65216162 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.65090200 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63918819 |
| 62 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.62999212 |
| 63 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62521966 |
| 64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61667448 |
| 65 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61583439 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.61370313 |
| 67 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60210930 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.59696825 |
| 69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57973773 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56752392 |
| 71 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.54910055 |
| 72 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53966951 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53430177 |
| 74 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53315833 |
| 75 | MAF_26560356_Chip-Seq_TH2_Human | 1.52841237 |
| 76 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51734475 |
| 77 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50967637 |
| 78 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50833507 |
| 79 | KDM2B_26808549_Chip-Seq_K562_Human | 1.50729381 |
| 80 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48771044 |
| 81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47622517 |
| 82 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.42604768 |
| 83 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.41897033 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40568815 |
| 85 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40245633 |
| 86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39823982 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.39763435 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39365174 |
| 89 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38981205 |
| 90 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38981205 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38441364 |
| 92 | CJUN_26792858_Chip-Seq_BT549_Human | 1.37487195 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37228844 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36146401 |
| 95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.36117969 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.34866992 |
| 97 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.34723831 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 1.34536034 |
| 99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.34453077 |
| 100 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.34391221 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34315754 |
| 102 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34313943 |
| 103 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33429958 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33106012 |
| 105 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32186170 |
| 106 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32095802 |
| 107 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30317612 |
| 108 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.30126922 |
| 109 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30081646 |
| 110 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.29114319 |
| 111 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.29082317 |
| 112 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.26775584 |
| 113 | MYB_26560356_Chip-Seq_TH1_Human | 1.25192711 |
| 114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24995013 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24813615 |
| 116 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24034780 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23882678 |
| 118 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.23080005 |
| 119 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.22044505 |
| 120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21494569 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21231151 |
| 122 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21130578 |
| 123 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21104321 |
| 124 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20884745 |
| 125 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20486066 |
| 126 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18758880 |
| 127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17911072 |
| 128 | MYB_26560356_Chip-Seq_TH2_Human | 1.17643605 |
| 129 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17412096 |
| 130 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17090513 |
| 131 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17090513 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16482697 |
| 133 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.16277451 |
| 134 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15916287 |
| 135 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15333734 |
| 136 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14961235 |
| 137 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14338398 |
| 138 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14140778 |
| 139 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14033995 |
| 140 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.12919413 |
| 141 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.12054451 |
| 142 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09507727 |
| 143 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09435826 |
| 144 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09291775 |
| 145 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08691723 |
| 146 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07254700 |
| 147 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06705714 |
| 148 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06571074 |
| 149 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04164611 |
| 150 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03413068 |
| 151 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03161974 |
| 152 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.02951316 |
| 153 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01279153 |
| 154 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99952702 |
| 155 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99779442 |
| 156 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98536477 |
| 157 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.98097596 |
| 158 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97510491 |
| 159 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97216432 |
| 160 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.96417130 |
| 161 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96371122 |
| 162 | P68_20966046_ChIP-Seq_HELA_Human | 0.96097510 |
| 163 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95998517 |
| 164 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.95994480 |
| 165 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95454123 |
| 166 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93594075 |
| 167 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93440005 |
| 168 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93250117 |
| 169 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.92857352 |
| 170 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91216379 |
| 171 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90495599 |
| 172 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90492674 |
| 173 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.90453819 |
| 174 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90423203 |
| 175 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88283257 |
| 176 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.88209933 |
| 177 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87741346 |
| 178 | P300_19829295_ChIP-Seq_ESCs_Human | 0.86828565 |
| 179 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86584541 |
| 180 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85379129 |
| 181 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85368989 |
| 182 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83609063 |
| 183 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82416591 |
| 184 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.81914420 |
| 185 | TBL1_22424771_ChIP-Seq_293T_Human | 0.81742052 |
| 186 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.81231436 |
| 187 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.80961821 |
| 188 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.80677724 |
| 189 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.79924118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.30712611 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.25767053 |
| 3 | MP0000751_myopathy | 3.62164808 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.54319432 |
| 5 | MP0000920_abnormal_myelination | 3.11697204 |
| 6 | MP0000749_muscle_degeneration | 2.98234238 |
| 7 | MP0003436_decreased_susceptibility_to | 2.97416982 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.85690476 |
| 9 | MP0005503_abnormal_tendon_morphology | 2.84848411 |
| 10 | MP0005275_abnormal_skin_tensile | 2.84346362 |
| 11 | MP0003303_peritoneal_inflammation | 2.62354876 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.51257053 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.44010053 |
| 14 | MP0004084_abnormal_cardiac_muscle | 2.42955177 |
| 15 | MP0003136_yellow_coat_color | 2.40753691 |
| 16 | MP0005171_absent_coat_pigmentation | 2.33191562 |
| 17 | MP0002419_abnormal_innate_immunity | 2.31037849 |
| 18 | MP0009278_abnormal_bone_marrow | 2.30395634 |
| 19 | MP0005330_cardiomyopathy | 2.28893683 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.15922833 |
| 21 | MP0004215_abnormal_myocardial_fiber | 2.06601092 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.04616746 |
| 23 | MP0001958_emphysema | 2.03471696 |
| 24 | MP0003646_muscle_fatigue | 2.03083080 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 2.00833373 |
| 26 | MP0001545_abnormal_hematopoietic_system | 2.00833373 |
| 27 | MP0004145_abnormal_muscle_electrophysio | 1.95096360 |
| 28 | MP0005451_abnormal_body_composition | 1.94729545 |
| 29 | MP0005025_abnormal_response_to | 1.89986742 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.89337975 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.84927998 |
| 32 | MP0006082_CNS_inflammation | 1.82350894 |
| 33 | MP0003137_abnormal_impulse_conducting | 1.80596043 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.80059288 |
| 35 | MP0009840_abnormal_foam_cell | 1.79611356 |
| 36 | MP0004947_skin_inflammation | 1.79397988 |
| 37 | MP0002132_abnormal_respiratory_system | 1.77642879 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.75760578 |
| 39 | MP0005387_immune_system_phenotype | 1.75413283 |
| 40 | MP0001790_abnormal_immune_system | 1.75413283 |
| 41 | MP0004087_abnormal_muscle_fiber | 1.74678363 |
| 42 | MP0002108_abnormal_muscle_morphology | 1.73798479 |
| 43 | MP0005620_abnormal_muscle_contractility | 1.72339246 |
| 44 | MP0005083_abnormal_biliary_tract | 1.72136365 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.70602508 |
| 46 | MP0000747_muscle_weakness | 1.69754665 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.62844327 |
| 48 | MP0005409_darkened_coat_color | 1.60922334 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.59957434 |
| 50 | MP0005369_muscle_phenotype | 1.58010293 |
| 51 | MP0003279_aneurysm | 1.57939788 |
| 52 | MP0002148_abnormal_hypersensitivity_rea | 1.57939364 |
| 53 | MP0003690_abnormal_glial_cell | 1.57870131 |
| 54 | MP0009785_altered_susceptibility_to | 1.57512402 |
| 55 | MP0000685_abnormal_immune_system | 1.56899639 |
| 56 | MP0004381_abnormal_hair_follicle | 1.56687365 |
| 57 | MP0004272_abnormal_basement_membrane | 1.56166146 |
| 58 | MP0005000_abnormal_immune_tolerance | 1.55352823 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.54608717 |
| 60 | MP0002106_abnormal_muscle_physiology | 1.54078189 |
| 61 | MP0000759_abnormal_skeletal_muscle | 1.53796071 |
| 62 | MP0008004_abnormal_stomach_pH | 1.49612364 |
| 63 | MP0000750_abnormal_muscle_regeneration | 1.49212206 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.46222714 |
| 65 | MP0002723_abnormal_immune_serum | 1.45165896 |
| 66 | MP0004484_altered_response_of | 1.43254008 |
| 67 | MP0002405_respiratory_system_inflammati | 1.42544454 |
| 68 | MP0000566_synostosis | 1.41542644 |
| 69 | MP0000762_abnormal_tongue_morphology | 1.41451304 |
| 70 | MP0004883_abnormal_blood_vessel | 1.41337271 |
| 71 | MP0000383_abnormal_hair_follicle | 1.39188294 |
| 72 | MP0002295_abnormal_pulmonary_circulatio | 1.38527810 |
| 73 | MP0003828_pulmonary_edema | 1.38213421 |
| 74 | MP0006138_congestive_heart_failure | 1.37877424 |
| 75 | MP0008775_abnormal_heart_ventricle | 1.37016897 |
| 76 | MP0004233_abnormal_muscle_weight | 1.36662232 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.35614634 |
| 78 | MP0001800_abnormal_humoral_immune | 1.34903252 |
| 79 | MP0004742_abnormal_vestibular_system | 1.33761139 |
| 80 | MP0002420_abnormal_adaptive_immunity | 1.33317067 |
| 81 | MP0001819_abnormal_immune_cell | 1.33246248 |
| 82 | MP0000579_abnormal_nail_morphology | 1.31610961 |
| 83 | MP0005164_abnormal_response_to | 1.31459912 |
| 84 | MP0000858_altered_metastatic_potential | 1.30380114 |
| 85 | MP0002933_joint_inflammation | 1.28364792 |
| 86 | MP0009384_cardiac_valve_regurgitation | 1.22777703 |
| 87 | MP0003634_abnormal_glial_cell | 1.22366189 |
| 88 | MP0003091_abnormal_cell_migration | 1.21815097 |
| 89 | MP0000678_abnormal_parathyroid_gland | 1.19851560 |
| 90 | MP0002396_abnormal_hematopoietic_system | 1.18336636 |
| 91 | MP0005385_cardiovascular_system_phenoty | 1.18213393 |
| 92 | MP0001544_abnormal_cardiovascular_syste | 1.18213393 |
| 93 | MP0005671_abnormal_response_to | 1.17693490 |
| 94 | MP0002060_abnormal_skin_morphology | 1.16667687 |
| 95 | MP0004134_abnormal_chest_morphology | 1.13741078 |
| 96 | MP0004808_abnormal_hematopoietic_stem | 1.12539413 |
| 97 | MP0003880_abnormal_central_pattern | 1.12459047 |
| 98 | MP0002398_abnormal_bone_marrow | 1.08142318 |
| 99 | MP0009115_abnormal_fat_cell | 1.07912351 |
| 100 | MP0004085_abnormal_heartbeat | 1.07867994 |
| 101 | MP0004142_abnormal_muscle_tone | 1.06967176 |
| 102 | MP0004510_myositis | 1.06799182 |
| 103 | MP0010630_abnormal_cardiac_muscle | 1.06663713 |
| 104 | MP0001845_abnormal_inflammatory_respons | 1.05668053 |
| 105 | MP0008469_abnormal_protein_level | 1.05023738 |
| 106 | MP0000733_abnormal_muscle_development | 1.04243375 |
| 107 | MP0005508_abnormal_skeleton_morphology | 1.03368401 |
| 108 | MP0010678_abnormal_skin_adnexa | 1.02925073 |
| 109 | MP0005023_abnormal_wound_healing | 1.02219048 |
| 110 | MP0002133_abnormal_respiratory_system | 1.02076983 |
| 111 | MP0005388_respiratory_system_phenotype | 1.02076983 |
| 112 | MP0000716_abnormal_immune_system | 1.01479027 |
| 113 | MP0002971_abnormal_brown_adipose | 1.01025129 |
| 114 | MP0002722_abnormal_immune_system | 0.99387641 |
| 115 | MP0003075_altered_response_to | 0.99226352 |
| 116 | MP0000343_altered_response_to | 0.98922219 |
| 117 | MP0002269_muscular_atrophy | 0.98351485 |
| 118 | MP0001486_abnormal_startle_reflex | 0.96956726 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.96733031 |
| 120 | MP0004270_analgesia | 0.96520430 |
| 121 | MP0003453_abnormal_keratinocyte_physiol | 0.94869114 |
| 122 | MP0003329_amyloid_beta_deposits | 0.94242632 |
| 123 | MP0003941_abnormal_skin_development | 0.94036899 |
| 124 | MP0002272_abnormal_nervous_system | 0.93425746 |
| 125 | MP0001853_heart_inflammation | 0.93302228 |
| 126 | MP0003045_fibrosis | 0.91930159 |
| 127 | MP0010368_abnormal_lymphatic_system | 0.91286911 |
| 128 | MP0001879_abnormal_lymphatic_vessel | 0.91271463 |
| 129 | MP0002429_abnormal_blood_cell | 0.91268472 |
| 130 | MP0002877_abnormal_melanocyte_morpholog | 0.90998597 |
| 131 | MP0004185_abnormal_adipocyte_glucose | 0.88569909 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.88440520 |
| 133 | MP0000689_abnormal_spleen_morphology | 0.88402290 |
| 134 | MP0003566_abnormal_cell_adhesion | 0.88149570 |
| 135 | MP0001346_abnormal_lacrimal_gland | 0.87773663 |
| 136 | MP0005165_increased_susceptibility_to | 0.87184322 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.85996196 |
| 138 | MP0000249_abnormal_blood_vessel | 0.85528701 |
| 139 | MP0010155_abnormal_intestine_physiology | 0.84840530 |
| 140 | MP0000467_abnormal_esophagus_morphology | 0.84384871 |
| 141 | MP0000778_abnormal_nervous_system | 0.83596245 |
| 142 | MP0009250_abnormal_appendicular_skeleto | 0.82901901 |
| 143 | MP0005595_abnormal_vascular_smooth | 0.82644555 |
| 144 | MP0009333_abnormal_splenocyte_physiolog | 0.82234488 |
| 145 | MP0005166_decreased_susceptibility_to | 0.81492207 |
| 146 | MP0006054_spinal_hemorrhage | 0.81070865 |
| 147 | MP0000462_abnormal_digestive_system | 0.81025049 |
| 148 | MP0004130_abnormal_muscle_cell | 0.80847722 |
| 149 | MP0001485_abnormal_pinna_reflex | 0.80642396 |
| 150 | MP0004885_abnormal_endolymph | 0.80218602 |
| 151 | MP0008260_abnormal_autophagy | 0.79578094 |
| 152 | MP0003632_abnormal_nervous_system | 0.78718117 |
| 153 | MP0003448_altered_tumor_morphology | 0.78326932 |
| 154 | MP0001542_abnormal_bone_strength | 0.78226739 |
| 155 | MP0009764_decreased_sensitivity_to | 0.76569199 |
| 156 | MP0005375_adipose_tissue_phenotype | 0.76560803 |
| 157 | MP0005390_skeleton_phenotype | 0.75650741 |
| 158 | MP0001905_abnormal_dopamine_level | 0.74973977 |
| 159 | MP0001177_atelectasis | 0.74481026 |
| 160 | MP0005666_abnormal_adipose_tissue | 0.74358126 |
| 161 | MP0000647_abnormal_sebaceous_gland | 0.70138809 |
| 162 | MP0002249_abnormal_larynx_morphology | 0.68663882 |
| 163 | MP0005670_abnormal_white_adipose | 0.67014116 |
| 164 | MP0001851_eye_inflammation | 0.66090658 |
| 165 | MP0002090_abnormal_vision | 0.66039309 |
| 166 | MP0003724_increased_susceptibility_to | 0.65370108 |
| 167 | MP0002796_impaired_skin_barrier | 0.65147045 |
| 168 | MP0001529_abnormal_vocalization | 0.62757598 |
| 169 | MP0002229_neurodegeneration | 0.61233151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber splitting (HP:0003555) | 5.91325437 |
| 2 | Hyporeflexia of lower limbs (HP:0002600) | 4.74083552 |
| 3 | Premature rupture of membranes (HP:0001788) | 4.29276953 |
| 4 | Sudden death (HP:0001699) | 4.26927232 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.17186301 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.00646725 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 3.99478604 |
| 8 | Polycythemia (HP:0001901) | 3.98248410 |
| 9 | Ventricular tachycardia (HP:0004756) | 3.85308034 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.84274212 |
| 11 | Atrial fibrillation (HP:0005110) | 3.82871427 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 3.78320529 |
| 13 | Difficulty running (HP:0009046) | 3.70278377 |
| 14 | Cholecystitis (HP:0001082) | 3.65724354 |
| 15 | Abnormal gallbladder physiology (HP:0012438) | 3.65724354 |
| 16 | Exercise-induced myalgia (HP:0003738) | 3.59773220 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 3.55591784 |
| 18 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.54675723 |
| 19 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.54675723 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.52906339 |
| 21 | Primary atrial arrhythmia (HP:0001692) | 3.47051723 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 3.41839683 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 3.38134733 |
| 24 | Neurofibrillary tangles (HP:0002185) | 3.35091493 |
| 25 | Broad metatarsal (HP:0001783) | 3.32507102 |
| 26 | Parakeratosis (HP:0001036) | 3.31632429 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.24709423 |
| 28 | Supraventricular tachycardia (HP:0004755) | 3.23405247 |
| 29 | Increased connective tissue (HP:0009025) | 3.21116599 |
| 30 | Exercise-induced muscle cramps (HP:0003710) | 3.19824494 |
| 31 | Supraventricular arrhythmia (HP:0005115) | 3.18746922 |
| 32 | Onion bulb formation (HP:0003383) | 3.09913198 |
| 33 | Spontaneous hematomas (HP:0007420) | 3.09872330 |
| 34 | Systemic lupus erythematosus (HP:0002725) | 3.05511196 |
| 35 | Lipoatrophy (HP:0100578) | 3.04751429 |
| 36 | Foot dorsiflexor weakness (HP:0009027) | 2.99499725 |
| 37 | Atrophic scars (HP:0001075) | 2.97621230 |
| 38 | Muscle fiber inclusion bodies (HP:0100299) | 2.89468598 |
| 39 | Syncope (HP:0001279) | 2.89196055 |
| 40 | Distal lower limb amyotrophy (HP:0008944) | 2.88776854 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.88403401 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 2.88296891 |
| 43 | Myositis (HP:0100614) | 2.87378627 |
| 44 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.87287937 |
| 45 | Obstructive lung disease (HP:0006536) | 2.84255623 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84255623 |
| 47 | Prolonged QT interval (HP:0001657) | 2.79905880 |
| 48 | Abnormality of the foot musculature (HP:0001436) | 2.79715867 |
| 49 | Reticulocytosis (HP:0001923) | 2.77035869 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 2.76536022 |
| 51 | Hypertensive crisis (HP:0100735) | 2.74328481 |
| 52 | Dilated cardiomyopathy (HP:0001644) | 2.72275454 |
| 53 | Orchitis (HP:0100796) | 2.68583926 |
| 54 | Sensory axonal neuropathy (HP:0003390) | 2.65893223 |
| 55 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.65763057 |
| 56 | Hypoplasia of the iris (HP:0007676) | 2.64134857 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.63456620 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.63456620 |
| 59 | Abnormality of glycolipid metabolism (HP:0010969) | 2.63456620 |
| 60 | Gowers sign (HP:0003391) | 2.62591169 |
| 61 | Dilatation of the ascending aorta (HP:0005111) | 2.60122615 |
| 62 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.59407888 |
| 63 | Neck muscle weakness (HP:0000467) | 2.59183695 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.56607265 |
| 65 | Scapular winging (HP:0003691) | 2.56152379 |
| 66 | Round ear (HP:0100830) | 2.56002899 |
| 67 | Truncus arteriosus (HP:0001660) | 2.55714330 |
| 68 | Nemaline bodies (HP:0003798) | 2.55098594 |
| 69 | Pulmonary artery stenosis (HP:0004415) | 2.54076493 |
| 70 | Spinal rigidity (HP:0003306) | 2.52855427 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 2.51061787 |
| 72 | Subaortic stenosis (HP:0001682) | 2.49738922 |
| 73 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.49738922 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.47455653 |
| 75 | Peritonitis (HP:0002586) | 2.46402631 |
| 76 | Fragile skin (HP:0001030) | 2.46266749 |
| 77 | Aortic aneurysm (HP:0004942) | 2.43212769 |
| 78 | Gingivitis (HP:0000230) | 2.41716019 |
| 79 | Ankyloglossia (HP:0010296) | 2.40337162 |
| 80 | Aplasia involving bones of the extremities (HP:0009825) | 2.39994813 |
| 81 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.39994813 |
| 82 | Aplasia of the phalanges of the hand (HP:0009802) | 2.39994813 |
| 83 | Prolonged bleeding time (HP:0003010) | 2.35840671 |
| 84 | Increased IgE level (HP:0003212) | 2.35659247 |
| 85 | Steppage gait (HP:0003376) | 2.35505137 |
| 86 | Abnormality of the fingertips (HP:0001211) | 2.34270778 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 2.33607015 |
| 88 | Optic neuritis (HP:0100653) | 2.33607015 |
| 89 | Axonal loss (HP:0003447) | 2.33267551 |
| 90 | Recurrent fungal infections (HP:0002841) | 2.32288659 |
| 91 | Lower limb amyotrophy (HP:0007210) | 2.31986445 |
| 92 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.29487891 |
| 93 | Recurrent skin infections (HP:0001581) | 2.29104554 |
| 94 | Myocardial infarction (HP:0001658) | 2.29086238 |
| 95 | Ulnar deviation of the wrist (HP:0003049) | 2.28497274 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 2.28221197 |
| 97 | Infantile muscular hypotonia (HP:0008947) | 2.27158181 |
| 98 | Bowel incontinence (HP:0002607) | 2.23544013 |
| 99 | Duplicated collecting system (HP:0000081) | 2.22192018 |
| 100 | Cerebral aneurysm (HP:0004944) | 2.21926678 |
| 101 | Alacrima (HP:0000522) | 2.21584726 |
| 102 | Nonimmune hydrops fetalis (HP:0001790) | 2.21565103 |
| 103 | Epistaxis (HP:0000421) | 2.21271076 |
| 104 | Peripheral hypomyelination (HP:0007182) | 2.21232322 |
| 105 | Hip contracture (HP:0003273) | 2.20639725 |
| 106 | Shallow orbits (HP:0000586) | 2.20201472 |
| 107 | Dysostosis multiplex (HP:0000943) | 2.18030792 |
| 108 | Stridor (HP:0010307) | 2.17975288 |
| 109 | Colitis (HP:0002583) | 2.16838240 |
| 110 | Limited hip movement (HP:0008800) | 2.15716340 |
| 111 | Myotonia (HP:0002486) | 2.15218433 |
| 112 | Esophageal varix (HP:0002040) | 2.15199476 |
| 113 | Abnormal large intestine physiology (HP:0012700) | 2.14849045 |
| 114 | Keratoconjunctivitis sicca (HP:0001097) | 2.12264010 |
| 115 | Cellulitis (HP:0100658) | 2.10275917 |
| 116 | Protrusio acetabuli (HP:0003179) | 2.09979407 |
| 117 | Bradycardia (HP:0001662) | 2.09929527 |
| 118 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.09519832 |
| 119 | Hemorrhage of the eye (HP:0011885) | 2.09307130 |
| 120 | Increased serum ferritin (HP:0003281) | 2.09300224 |
| 121 | Weak cry (HP:0001612) | 2.07954970 |
| 122 | Cerebral inclusion bodies (HP:0100314) | 2.07742969 |
| 123 | Bundle branch block (HP:0011710) | 2.07546350 |
| 124 | Cholelithiasis (HP:0001081) | 2.07490611 |
| 125 | Abnormality of the corticospinal tract (HP:0002492) | 2.07398263 |
| 126 | Aneurysm (HP:0002617) | 2.06652691 |
| 127 | Myopathic facies (HP:0002058) | 2.05262591 |
| 128 | Increased cerebral lipofuscin (HP:0011813) | 2.04810564 |
| 129 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.03969310 |
| 130 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.03969310 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.03969310 |
| 132 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03876829 |
| 133 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03876829 |
| 134 | Pustule (HP:0200039) | 2.03363755 |
| 135 | Follicular hyperkeratosis (HP:0007502) | 2.01735109 |
| 136 | Abnormality of the peritoneum (HP:0002585) | 2.01537217 |
| 137 | Mucopolysacchariduria (HP:0008155) | 2.01160388 |
| 138 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01160388 |
| 139 | Atelectasis (HP:0100750) | 2.00257079 |
| 140 | Amyloidosis (HP:0011034) | 1.99664693 |
| 141 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.99172255 |
| 142 | Bell-shaped thorax (HP:0001591) | 1.98565719 |
| 143 | Hyperthyroidism (HP:0000836) | 1.98116548 |
| 144 | Abnormality of the tricuspid valve (HP:0001702) | 1.96594377 |
| 145 | Ventricular arrhythmia (HP:0004308) | 1.96353722 |
| 146 | Premature skin wrinkling (HP:0100678) | 1.96192872 |
| 147 | Acne (HP:0001061) | 1.95953489 |
| 148 | Mediastinal lymphadenopathy (HP:0100721) | 1.94581254 |
| 149 | Diaphragmatic weakness (HP:0009113) | 1.93949678 |
| 150 | Abnormality of complement system (HP:0005339) | 1.92674509 |
| 151 | Arterial thrombosis (HP:0004420) | 1.91970527 |
| 152 | Abnormality of oral frenula (HP:0000190) | 1.89973474 |
| 153 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89763535 |
| 154 | Abnormal atrioventricular conduction (HP:0005150) | 1.89608517 |
| 155 | Muscular dystrophy (HP:0003560) | 1.87258572 |
| 156 | Gastrointestinal dysmotility (HP:0002579) | 1.86936114 |
| 157 | Keratoconjunctivitis (HP:0001096) | 1.86649186 |
| 158 | Seborrheic dermatitis (HP:0001051) | 1.86562382 |
| 159 | Synostosis involving the elbow (HP:0003938) | 1.84845605 |
| 160 | Humeroradial synostosis (HP:0003041) | 1.84845605 |
| 161 | Absent septum pellucidum (HP:0001331) | 1.84569419 |
| 162 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.84558005 |
| 163 | Hypertriglyceridemia (HP:0002155) | 1.84007565 |
| 164 | Soft skin (HP:0000977) | 1.82897514 |
| 165 | Muscle stiffness (HP:0003552) | 1.82386810 |
| 166 | Large for gestational age (HP:0001520) | 1.82334762 |
| 167 | Metaphyseal cupping (HP:0003021) | 1.82142562 |
| 168 | Abnormal EKG (HP:0003115) | 1.81065167 |
| 169 | Cervical subluxation (HP:0003308) | 1.79998477 |
| 170 | Hemoptysis (HP:0002105) | 1.78159419 |
| 171 | Heart block (HP:0012722) | 1.77624261 |
| 172 | Double outlet right ventricle (HP:0001719) | 1.77139870 |
| 173 | Congenital malformation of the right heart (HP:0011723) | 1.77139870 |
| 174 | Coronal craniosynostosis (HP:0004440) | 1.76570905 |
| 175 | Abnormality of the renal collecting system (HP:0004742) | 1.76358844 |
| 176 | White forelock (HP:0002211) | 1.76349568 |
| 177 | Fragile nails (HP:0001808) | 1.76241106 |
| 178 | Aortic dissection (HP:0002647) | 1.76039509 |
| 179 | Abnormality of the common coagulation pathway (HP:0010990) | 1.75637117 |
| 180 | Gingival bleeding (HP:0000225) | 1.75165643 |
| 181 | Venous abnormality (HP:0002624) | 1.74614742 |
| 182 | Thickened helices (HP:0000391) | 1.74274767 |
| 183 | Abnormal auditory evoked potentials (HP:0006958) | 1.72610478 |
| 184 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.72289013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.31914218 |
| 2 | RIPK4 | 4.10508552 |
| 3 | EPHB1 | 3.54858441 |
| 4 | TTN | 3.43888048 |
| 5 | ERN1 | 2.99079298 |
| 6 | OBSCN | 2.85700580 |
| 7 | PKN1 | 2.79319935 |
| 8 | KSR2 | 2.64036649 |
| 9 | MAP2K3 | 2.63955805 |
| 10 | OXSR1 | 2.55249530 |
| 11 | PHKG1 | 2.41250591 |
| 12 | PHKG2 | 2.41250591 |
| 13 | TRIB3 | 2.33966876 |
| 14 | TYK2 | 2.32881536 |
| 15 | MUSK | 2.20812021 |
| 16 | DMPK | 2.03691300 |
| 17 | CASK | 1.92737086 |
| 18 | TRPM7 | 1.83142574 |
| 19 | CAMK2D | 1.81434894 |
| 20 | ZAP70 | 1.79323256 |
| 21 | WNK4 | 1.76139513 |
| 22 | CDK12 | 1.75717824 |
| 23 | MAP3K2 | 1.74698441 |
| 24 | PIK3CA | 1.72024534 |
| 25 | MET | 1.69370876 |
| 26 | WNK1 | 1.68580731 |
| 27 | EEF2K | 1.67981820 |
| 28 | JAK3 | 1.67722088 |
| 29 | ROCK2 | 1.67453230 |
| 30 | MAPKAPK5 | 1.66819042 |
| 31 | BCR | 1.62243012 |
| 32 | MAP3K6 | 1.59385395 |
| 33 | MYLK | 1.59032444 |
| 34 | TIE1 | 1.56348414 |
| 35 | MAP3K1 | 1.55943084 |
| 36 | CSK | 1.55636647 |
| 37 | FGFR2 | 1.49215510 |
| 38 | NEK6 | 1.45024562 |
| 39 | IRAK4 | 1.42798144 |
| 40 | RAF1 | 1.41595617 |
| 41 | EPHB2 | 1.39803945 |
| 42 | PAK3 | 1.35609576 |
| 43 | MAP3K3 | 1.33938095 |
| 44 | JAK2 | 1.31906397 |
| 45 | PBK | 1.29573369 |
| 46 | PRKD1 | 1.28776335 |
| 47 | CAMK2B | 1.27610627 |
| 48 | GRK7 | 1.24359706 |
| 49 | FGFR4 | 1.21765686 |
| 50 | SIK1 | 1.21450156 |
| 51 | MST4 | 1.20517468 |
| 52 | IRAK3 | 1.20250067 |
| 53 | PRKCE | 1.20015577 |
| 54 | BMPR2 | 1.19253885 |
| 55 | INSRR | 1.17794885 |
| 56 | CLK1 | 1.16691189 |
| 57 | CAMK2G | 1.16598076 |
| 58 | DDR2 | 1.15826364 |
| 59 | MAP4K1 | 1.12912733 |
| 60 | BTK | 1.10943708 |
| 61 | HCK | 1.09882899 |
| 62 | FES | 1.05139908 |
| 63 | PINK1 | 1.04366979 |
| 64 | JAK1 | 1.04252611 |
| 65 | LMTK2 | 1.04032405 |
| 66 | TBK1 | 1.02594715 |
| 67 | LATS1 | 0.99268502 |
| 68 | TAOK2 | 0.99125942 |
| 69 | EPHA3 | 0.98924579 |
| 70 | CAMK2A | 0.98170694 |
| 71 | PTK6 | 0.97774580 |
| 72 | BMPR1B | 0.96511650 |
| 73 | KSR1 | 0.95352640 |
| 74 | PKN2 | 0.92360294 |
| 75 | ICK | 0.92142249 |
| 76 | RIPK1 | 0.91810240 |
| 77 | SGK223 | 0.91596656 |
| 78 | SGK494 | 0.91596656 |
| 79 | MAPK15 | 0.89731274 |
| 80 | MAP3K13 | 0.87892524 |
| 81 | SYK | 0.86728945 |
| 82 | FGR | 0.86658112 |
| 83 | PRPF4B | 0.86573585 |
| 84 | ZAK | 0.86239843 |
| 85 | MTOR | 0.85994648 |
| 86 | PAK6 | 0.85851364 |
| 87 | PIK3CG | 0.83980878 |
| 88 | ROCK1 | 0.83644365 |
| 89 | EPHA2 | 0.82274936 |
| 90 | RET | 0.80792083 |
| 91 | MAP3K8 | 0.80764921 |
| 92 | NUAK1 | 0.80701419 |
| 93 | CAMK1D | 0.79612546 |
| 94 | CSNK1A1L | 0.78935068 |
| 95 | PDGFRA | 0.78147434 |
| 96 | BLK | 0.77048371 |
| 97 | NTRK1 | 0.75514899 |
| 98 | TNK2 | 0.75255080 |
| 99 | TAOK1 | 0.72617785 |
| 100 | FGFR3 | 0.70121916 |
| 101 | MARK3 | 0.69753911 |
| 102 | MARK2 | 0.69577299 |
| 103 | RPS6KA2 | 0.69253317 |
| 104 | PRKCH | 0.69137741 |
| 105 | GRK6 | 0.68992467 |
| 106 | EPHA4 | 0.66880671 |
| 107 | NME1 | 0.66433317 |
| 108 | MAP2K1 | 0.66352841 |
| 109 | MAP3K7 | 0.65900283 |
| 110 | PDK2 | 0.64692688 |
| 111 | PRKCQ | 0.64633816 |
| 112 | YES1 | 0.64538429 |
| 113 | RPS6KC1 | 0.64011213 |
| 114 | RPS6KL1 | 0.64011213 |
| 115 | PRKG1 | 0.63866637 |
| 116 | MATK | 0.63126330 |
| 117 | PDK1 | 0.60572512 |
| 118 | UHMK1 | 0.60104015 |
| 119 | PRKD2 | 0.59749634 |
| 120 | STK38 | 0.59716067 |
| 121 | LATS2 | 0.59303923 |
| 122 | MAP3K14 | 0.59043943 |
| 123 | LYN | 0.58827581 |
| 124 | MAP2K2 | 0.58119926 |
| 125 | FER | 0.58074284 |
| 126 | PDGFRB | 0.56210234 |
| 127 | GSK3A | 0.54275366 |
| 128 | HIPK2 | 0.54068343 |
| 129 | MAPK12 | 0.53925798 |
| 130 | NEK9 | 0.53519584 |
| 131 | LIMK1 | 0.53369693 |
| 132 | CSNK1G3 | 0.53014355 |
| 133 | PRKAA2 | 0.52589057 |
| 134 | SMG1 | 0.52451605 |
| 135 | PTK2B | 0.51845252 |
| 136 | LCK | 0.51647088 |
| 137 | TNIK | 0.51092550 |
| 138 | IRAK1 | 0.50626177 |
| 139 | IKBKE | 0.50009566 |
| 140 | GRK1 | 0.49869207 |
| 141 | KIT | 0.49333087 |
| 142 | CDK19 | 0.49026139 |
| 143 | TAOK3 | 0.48841052 |
| 144 | PRKG2 | 0.48828288 |
| 145 | PDPK1 | 0.48779348 |
| 146 | AKT3 | 0.48385343 |
| 147 | MAPKAPK2 | 0.48136184 |
| 148 | RPS6KA6 | 0.48021091 |
| 149 | IKBKB | 0.47835182 |
| 150 | BMX | 0.47178096 |
| 151 | CSNK1G1 | 0.46974647 |
| 152 | STK10 | 0.46947937 |
| 153 | MAP2K6 | 0.46870910 |
| 154 | ILK | 0.46025278 |
| 155 | STK4 | 0.44424961 |
| 156 | TGFBR2 | 0.44381431 |
| 157 | PAK2 | 0.44087283 |
| 158 | PRKACB | 0.43814965 |
| 159 | CDC42BPA | 0.42996428 |
| 160 | PRKACA | 0.42367939 |
| 161 | RPS6KA5 | 0.40322368 |
| 162 | MAPK7 | 0.40064658 |
| 163 | IRAK2 | 0.39792339 |
| 164 | SGK1 | 0.39754629 |
| 165 | DAPK3 | 0.39673627 |
| 166 | CAMK1G | 0.39634836 |
| 167 | FYN | 0.39089217 |
| 168 | DYRK2 | 0.38925309 |
| 169 | STK3 | 0.35652796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.00338786 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.70547281 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.25413060 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.96139873 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.95109474 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.66312559 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.62194859 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.59443900 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.54705130 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44399135 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.38342594 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.37143025 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.36671428 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.23687146 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.05959469 |
| 16 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.97886603 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.83602331 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78369977 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.77249820 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.76878736 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74558763 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73710348 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.68761669 |
| 24 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.68494629 |
| 25 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.65397638 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61684888 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51503953 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44298274 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.42359454 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.40841840 |
| 31 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.39806667 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.38003471 |
| 33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37707936 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31900224 |
| 35 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31245532 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 1.30736199 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.30595127 |
| 38 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.29953582 |
| 39 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.29381394 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28959407 |
| 41 | Focal adhesion_Homo sapiens_hsa04510 | 1.28823640 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28755574 |
| 43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28587212 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27282832 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25599280 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.24260806 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 1.24114432 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.18437546 |
| 49 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.18079837 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.15285171 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14316329 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.12875843 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12756049 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12321278 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11278161 |
| 56 | Measles_Homo sapiens_hsa05162 | 1.10765536 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10575302 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08923213 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 1.08750681 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.07531661 |
| 61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.04471549 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 1.03280112 |
| 63 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.03077249 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03057700 |
| 65 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02950616 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.02495487 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01746787 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01709266 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00727396 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00181559 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.99765259 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99279383 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.96647761 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.94825985 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.94198038 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.93166057 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.92715115 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92005937 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.89671011 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89102433 |
| 81 | Amoebiasis_Homo sapiens_hsa05146 | 0.89077452 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88123648 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88114230 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86217372 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.85892062 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85763215 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85659393 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83542565 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.83049476 |
| 90 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82170158 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81885114 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81617657 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.81442674 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.80295277 |
| 95 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80190450 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.80093824 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.79761725 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79440708 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.78361428 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.78309410 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78061502 |
| 102 | Salivary secretion_Homo sapiens_hsa04970 | 0.76777365 |
| 103 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76750154 |
| 104 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75960526 |
| 105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75761609 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75117154 |
| 107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72367870 |
| 108 | GABAergic synapse_Homo sapiens_hsa04727 | 0.70721826 |
| 109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70666181 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70536532 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69770880 |
| 112 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.69597340 |
| 113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69506307 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.69217526 |
| 115 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68854779 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68836261 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67795333 |
| 118 | Circadian entrainment_Homo sapiens_hsa04713 | 0.67061559 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64870884 |
| 120 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64671266 |
| 121 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64543493 |
| 122 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63895198 |
| 123 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63843872 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63625765 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.63615902 |
| 126 | Allograft rejection_Homo sapiens_hsa05330 | 0.63325424 |
| 127 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62410129 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.62113405 |
| 129 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60810932 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60191781 |
| 131 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58629144 |
| 132 | Phototransduction_Homo sapiens_hsa04744 | 0.58322205 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57270853 |
| 134 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55904867 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.55789768 |
| 136 | Cocaine addiction_Homo sapiens_hsa05030 | 0.55047333 |
| 137 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54752561 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54647528 |
| 139 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54325929 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53677704 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53519381 |
| 142 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52313427 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51945864 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.51409022 |
| 145 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50897543 |
| 146 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.50867735 |
| 147 | Melanogenesis_Homo sapiens_hsa04916 | 0.50631424 |
| 148 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50590797 |
| 149 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49755909 |
| 150 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49159140 |
| 151 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48716314 |
| 152 | Glioma_Homo sapiens_hsa05214 | 0.48116852 |
| 153 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47858474 |
| 154 | Adherens junction_Homo sapiens_hsa04520 | 0.46947535 |
| 155 | Prostate cancer_Homo sapiens_hsa05215 | 0.46891643 |
| 156 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46223299 |
| 157 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45880323 |
| 158 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45296352 |
| 159 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44853427 |
| 160 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44549225 |
| 161 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.43575281 |
| 162 | Long-term depression_Homo sapiens_hsa04730 | 0.42646835 |
| 163 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42367127 |
| 164 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41733538 |
| 165 | ABC transporters_Homo sapiens_hsa02010 | 0.40597502 |
| 166 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39756434 |
| 167 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39700363 |
| 168 | Salmonella infection_Homo sapiens_hsa05132 | 0.39470198 |
| 169 | Pathways in cancer_Homo sapiens_hsa05200 | 0.37997005 |
| 170 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37913083 |
| 171 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36517349 |
| 172 | Platelet activation_Homo sapiens_hsa04611 | 0.34681521 |
| 173 | Endocytosis_Homo sapiens_hsa04144 | 0.34068901 |

